38 research outputs found
Site-specific modification of the lactose operator with acetylaminofluorene.
No full textWe have synthesized the tetradecamer GAGCXGATAACAAG containing a part of the sequence of the lactose operator. A guanine base in the sequence is replaced by the adduct of the carcinogen 2-acetylaminofluorene with guanine. Under the standard conditions of de-protection, the fluorene moiety is lost, leaving behind a guanine oxidation product. New conditions of de-protection have been developed which allow the isolation of an oligonucleotide containing the adduct of 2-aminofluorene with guanine. The presence of the aminofluorene adduct greatly increases retention on reverse phase chromatography and produces a unique pattern of sequencing bands
647Is the outcome of multifocal botulinum a toxin BT.A in svere neurogenic detrusor overactivity NDO predictable — An urodynamic analysis
No full text407Efficacy, dosage and safety of dysport english botulinum toxin a in severe neurogenic detrusor overactivity NDO
No full text
Identification of two new metabolites of caffeine in the rat urine
Full text linkL'acide 1, 3, 7-triméthyldihydro-urique et la 3, 6, 8-triméthylallantoïne ont été identifiés comme métabolites nouveaux de la cafféine dans l'urine de rat.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/42553/1/18_2005_Article_BF01930396.pd
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence
No full textAn integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction
No full textDiagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients
No full text
